Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers

被引:185
作者
Walley, Alexander Y. [1 ,2 ,3 ]
Alperen, Julie K. [4 ]
Cheng, Debbie M. [1 ,2 ,5 ]
Botticelli, Michael [3 ]
Castro-Donlan, Carolyn [3 ]
Samet, Jeffrey H. [1 ,2 ,6 ]
Alford, Daniel P. [1 ,2 ]
机构
[1] Boston Med Ctr, Gen Internal Med Sect, Clin Addict Res & Educ Unit, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Massachusetts Dept Publ Hlth, Bur Subst Abuse Serv, Boston, MA USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[5] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[6] Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA
关键词
opioid dependence; buprenorphine; medication assisted treatment;
D O I
10.1007/s11606-008-0686-x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Buprenorphine is a safe, effective and underutilized treatment for opioid dependence that requires special credentialing, known as a waiver, to prescribe in the United States. OBJECTIVE: To describe buprenorphine clinical practices and barriers among office-based physicians. DESIGN: Cross-sectional survey. PARTICIPANTS: Two hundred thirty-five office-based physicians waivered to prescribe buprenorphine in Massachusetts. MEASUREMENTS: Questionnaires mailed to all waivered physicians in Massachusetts in October and November 2005 included questions on medical specialty, practice setting, clinical practices, and barriers to prescribing. Logistic regression analyses were used to identify factors associated with prescribing. RESULTS: Prescribers were 66% of respondents and prescribed to a median of ten patients. Clinical practices included mandatory counseling (79%), drug screening (82%), observed induction (57%), linkage to methadone maintenance (40%), and storing buprenorphine notes separate from other medical records (33%). Most non-prescribers (54%) reported they would prescribe if barriers were reduced. Being a primary care physician compared to a psychiatrist (AOR: 3.02; 95% CI: 1.48-6.18) and solo practice only compared to group practice (AOR: 3.01; 95% CI: 1.23-7.35) were associated with prescribing, while reporting low patient demand (AOR: 0.043, 95% CI: 0.009-0.21) and insufficient institutional support (AOR: 0.37; 95% CI: 0.15-0.89) were associated with not prescribing. CONCLUSIONS: Capacity for increased buprenorphine prescribing exists among physicians who have already obtained a waiver to prescribe. Increased efforts to link waivered physicians with opioid-dependent patients and initiatives to improve institutional support may mitigate barriers to buprenorphine treatment. Several guideline-driven practices have been widely adopted, such as adjunctive counseling and monitoring patients with drug screening.
引用
收藏
页码:1393 / 1398
页数:6
相关论文
共 21 条
[1]   Treating homeless opioid dependent patients with buprenorphine in an office-based setting [J].
Alford, Daniel P. ;
LaBelle, Colleen T. ;
Richardson, Jessica M. ;
O'Connell, James J. ;
Hohl, Carole A. ;
Cheng, Debbie M. ;
Samet, Jeffrey H. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (02) :171-176
[2]  
Becker WC., 2006, SUBST ABUS, V26, P15
[3]  
BIVOL S, 2003, NATL POLL PHYS BARRI
[4]  
*CTR HLTH INF STAT, OP TRENDS CURR STAT
[5]  
*CTR SUBST AB TREA, TREATM IMPR PROT TIP, V40
[6]   Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians [J].
Cunningham, Chinazo O. ;
Kunins, Hillary V. ;
Roose, Robert J. ;
Elam, Rashiah T. ;
Sohler, Nancy L. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (09) :1325-1329
[7]   Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone [J].
Fudala, PJ ;
Bridge, TP ;
Herbert, S ;
Williford, WO ;
Chiang, CN ;
Jones, K ;
Collins, J ;
Raisch, D ;
Casadonte, P ;
Goldsmith, RJ ;
Ling, W ;
Malkerneker, U ;
McNicholas, L ;
Renner, J ;
Stine, S ;
Tusel, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10) :949-958
[8]  
Gaulier JM, 2000, J FORENSIC SCI, V45, P226
[9]   A CONTROLLED TRIAL OF BUPRENORPHINE TREATMENT FOR OPIOID DEPENDENCE [J].
JOHNSON, RE ;
JAFFE, JH ;
FUDALA, PJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (20) :2750-2755
[10]   A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. [J].
Johnson, RE ;
Chutuape, MA ;
Strain, EC ;
Walsh, SL ;
Stitzer, ML ;
Bigelow, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (18) :1290-1297